GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Boston Scientific BSX · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500

Compare

44.02

+2.97%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

37 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 8Strong buy
  • 16Buy
  • 12Hold
  • 1Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 44.02Average target 66.50

Low
50.00
Average
66.50
Median
63.50
High
100.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$21.09bn$21.57bn$22.84bn$24.27bn$26.65bn
Revenue, highest$21.17bn$22.47bn$23.88bn$24.91bn$27.36bn
Revenue, lowest$20.96bn$21.12bn$20.72bn$23.36bn$25.65bn
Earnings per share3.203.253.543.874.11
Earnings per share, highest3.293.453.774.004.25
Earnings per share, lowest3.043.093.443.683.91
Analysts1121221411

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.730.830.790.790.720.730.680.66
Reported0.730.860.800.800.750.750.750.70
Difference+0.4%+3.0%+0.7%+1.6%+4.1%+2.5%+10.6%+5.6%

Rating changes

Latest broker notes

  • Argus ResearchBuy → Hold
  • Wells FargoEqual Weight
  • UBSBuy
  • Truist SecuritiesBuy
  • TD CowenBuy
  • RBC CapitalOutperform
  • Evercore ISI GroupOutperform
  • CitigroupBuy
  • Canaccord GenuityBuy
  • BTIGBuy
  • OppenheimerOutperform
  • Truist SecuritiesBuy

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 10.4% a year over 10 years. Return on equity 11.9%.

Model fair value

139.85

From earnings 139.85, from revenue 89.92.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.